Sabra Healthcare REIT, Inc. $SBRA Shares Sold by Bank of America Corp DE

Bank of America Corp DE lowered its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 8.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,409,161 shares of the real estate investment trust's stock after selling 493,377 shares during the quarter. Bank of America Corp DE owned approximately 2.14% of Sabra Healthcare REIT worth $104,018,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the stock. Focus Partners Wealth increased its position in shares of Sabra Healthcare REIT by 11.4% during the first quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust's stock worth $404,000 after purchasing an additional 2,375 shares in the last quarter. EverSource Wealth Advisors LLC increased its position in shares of Sabra Healthcare REIT by 150.7% during the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust's stock valued at $47,000 after acquiring an additional 1,536 shares during the last quarter. First Trust Advisors LP raised its stake in shares of Sabra Healthcare REIT by 27.2% in the 2nd quarter. First Trust Advisors LP now owns 368,383 shares of the real estate investment trust's stock valued at $6,793,000 after acquiring an additional 78,709 shares during the period. Cerity Partners LLC raised its stake in shares of Sabra Healthcare REIT by 73.0% in the 2nd quarter. Cerity Partners LLC now owns 18,686 shares of the real estate investment trust's stock valued at $345,000 after acquiring an additional 7,885 shares during the period. Finally, Daiwa Securities Group Inc. lifted its holdings in shares of Sabra Healthcare REIT by 3.1% in the 2nd quarter. Daiwa Securities Group Inc. now owns 83,889 shares of the real estate investment trust's stock worth $1,547,000 after acquiring an additional 2,557 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Scotiabank cut their target price on Sabra Healthcare REIT from $22.00 to $19.00 and set a "sector perform" rating on the stock in a research report on Thursday, June 18th. Weiss Ratings cut Sabra Healthcare REIT from a "buy (b)" rating to a "hold (c+)" rating in a research note on Tuesday. Barclays assumed coverage on Sabra Healthcare REIT in a report on Tuesday, July 7th. They issued an "overweight" rating and a $21.00 price objective on the stock. Deutsche Bank Aktiengesellschaft reissued a "buy" rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Finally, Raymond James Financial upgraded Sabra Healthcare REIT from an "underperform" rating to a "market perform" rating in a report on Thursday. Seven investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $22.25.

Sabra Healthcare REIT Stock Performance

NASDAQ SBRA opened at $21.04 on Friday. The company has a fifty day moving average of $19.82 and a two-hundred day moving average of $19.98. The company has a market capitalization of $5.37 billion, a PE ratio of 80.93, a P/E/G ratio of 1.62 and a beta of 0.64. Sabra Healthcare REIT, Inc. has a 1 year low of $17.17 and a 1 year high of $22.77. The company has a debt-to-equity ratio of 0.95, a current ratio of 3.07 and a quick ratio of 4.72.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of $0.17 by ($0.27). Sabra Healthcare REIT had a return on equity of 2.34% and a net margin of 7.61%.The firm had revenue of $230.11 million for the quarter, compared to analyst estimates of $219.39 million. During the same quarter last year, the firm posted $0.38 EPS. The firm's revenue for the quarter was up 24.7% on a year-over-year basis. As a group, analysts expect that Sabra Healthcare REIT, Inc. will post 1.51 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, August 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.7%. Sabra Healthcare REIT's dividend payout ratio (DPR) is 461.54%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc NASDAQ: SBRA is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra's tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source